- FoI Number
- 2024-465
- Subject
- Weight Loss Medications
- Date Received
- 05/11/2024
- Request and Response
-
- How much has this health board spent on weight loss medication in each year since 2019/20? This includes drugs like Liraglutide, Semaglutide and Tirzepatide.
With regards to primary care spend then in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 25(1) as the information requested is accessible without submitting a request under FOISA s 1(1). The information you have requested is available here:
https://www.opendata.nhs.scot/dataset/prescribed-dispensed
It should be noted that GLP-1s are not currently prescribed by NHS Shetland for weight loss, so any costs incurred are linked to their prescribing for patients with type 2 diabetes.
Orlistat is the only weight loss medication prescribed in NHS Shetland.
- How many individuals have been prescribed weight loss drugs in this health board in each year since 2019/20?
This is only Orlistat as the others do not apply as no use.
BNF Section Description
No of Individuals
2019
32
2020
19
2021
16
2022
21
2023
30
2024
21